Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.
about
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionShort-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsPretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channelTelmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.CMR of microvascular obstruction and hemorrhage in myocardial infarction.Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic SignificanceTemporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical ImplicationsManagement of 'no-reflow' complicating reperfusion therapy.Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.Clinical Predictors of Incomplete ST-Segment Resolution in the Patients With Acute ST Segment Elevation Myocardial Infarction.No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives.Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study.New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction.The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters.Magnetic resonance imaging characterization of circumferential and longitudinal strain under various coronary interventions in swine.Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.
P2860
Q26740252-A335AF82-917F-4E15-ABBB-8254E7D0852AQ26778578-58E70F8F-B10D-4992-9993-A14311C532CCQ30498652-C8360E58-B704-45AA-8DAD-0574BB3AD3D8Q34759513-326A5110-BFBB-4292-A717-DF9FF4A623B4Q35068344-B10EE8B0-DFBE-426B-8280-E639CCB5B685Q35387131-148D6A09-1DE3-41D5-8307-48039F0CC584Q36444582-A5334349-A7F6-4CE3-BFFF-49EA8B94091BQ36477868-8F0BE34D-DB3C-4C6F-BE45-ACE26ADB375EQ36714000-22FF85DA-8236-45CD-85E4-350FFF08C5ECQ37152013-74A718AF-482A-4EB5-B5E2-CC2F68592446Q37231298-EF820D79-91F4-458B-AF1F-964D3727CDC7Q37408793-FCB62091-3B7B-44AD-BFBE-A1FF7B595D0CQ38077760-4E978336-F324-4136-9AE1-61FCC466F4A9Q38605332-514D9554-A39D-4F77-9799-87ED03253460Q38797894-A08ACD24-9834-4CC2-B919-A1FD6C2A0178Q40612721-51F86F88-935E-4FCD-97C0-0147F4B78E8CQ41896943-B4D7A808-3EB0-4538-95DE-6AB62A0A8EF6Q42434791-1430DB54-79CC-4E74-8176-1BD5DF7C9ACBQ47214833-8F4575DF-5856-4D21-88B1-5BE04F1C6689
P2860
Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Optimal therapeutic strategies ...... a pathogenetic classification.
@en
Optimal therapeutic strategies ...... a pathogenetic classification.
@nl
type
label
Optimal therapeutic strategies ...... a pathogenetic classification.
@en
Optimal therapeutic strategies ...... a pathogenetic classification.
@nl
prefLabel
Optimal therapeutic strategies ...... a pathogenetic classification.
@en
Optimal therapeutic strategies ...... a pathogenetic classification.
@nl
P2860
P356
P1433
P1476
Optimal therapeutic strategies ...... a pathogenetic classification.
@en
P2093
P2860
P304
P356
10.1136/HRT.2003.020800
P407
P577
2004-02-01T00:00:00Z